# Concurrency Report

## Executive Summary
The application uses Prisma transactions for the core clinical mutations that affect prescriptions and stock movement. This is a strong baseline for concurrency safety, but it was not exercised under parallel stress in this environment.

## Findings
- Prescription creation and stock movement are transaction-bound.
- Queue and appointment transitions remain atomic at the action layer.

## Evidence
- Reviewed implementation in src/actions/clinical-slice3.actions.ts and src/actions/clinical-slice2.actions.ts.

## Risk Level
Medium

## Critical Issues
- No concurrent multi-user stress test was executed.
- No deadlock or retry behavior validation was executed against a real database instance.

## Recommendations
- Run concurrent reservation tests in staging with realistic contention.

## Pass / Fail
Pass for code-path design; Not Executed for live concurrency testing.
